TriMedika Limited – Trademark Portfolio

Entity Type: 99

TriMedika Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include TRIMEDIKA. The owner is based in Belfast.

Unit 3, e3 Building, Springvale Campus

398 Springfield Road

Belfast BT127DU , GB

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TriMedika Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does TriMedika Limited have?

TriMedika Limited has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 4 abandoned.

What trademark classes does TriMedika Limited file in?

TriMedika Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are TriMedika Limited's most well-known trademarks?

TriMedika Limited's registered trademark portfolio includes well-known marks such as TRIMEDIKA. These are among 1 currently registered trademark in the portfolio.

What is TriMedika Limited's trademark registration success rate?

TriMedika Limited has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.